Sign In
Buy ALIM
$5.54
+0 (+0%)
At Close: Dec 12, 2024
ANI Pharmaceuticals, Inc. Completes Acquisition of Alimera Sciences
08:53am, Monday, 16'th Sep 2024
PRINCETON, N.J., Sept. 16, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (“ANI” or “the Company”) (Nasdaq: ANIP) today announced the completion of its previously announced acquisition of
ANI Pharmaceuticals Initiates Closing of Acquisition of Alimera Sciences
06:50am, Monday, 16'th Sep 2024
PRINCETON, N.J., Sept. 16, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) (“ANI” or the “Company”) announced today that the Company has initiated closing logistics for the p
Alimera Sciences (ALIM) Soars 6.6%: Is Further Upside Left in the Stock?
09:30am, Thursday, 12'th Sep 2024
Alimera Sciences (ALIM) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price inc
ANI Pharmaceuticals Provides Update on Closing of Acquisition of Alimera Sciences
02:09pm, Tuesday, 10'th Sep 2024
PRINCETON, N.J., Sept. 10, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (“ANI” or “the Company”) (Nasdaq: ANIP) today provided an update on the status of the completion of its previously
Alimera Sciences (ALIM) Reports Q2 Loss, Tops Revenue Estimates
09:40am, Tuesday, 06'th Aug 2024
Alimera Sciences (ALIM) came out with a quarterly loss of $0.06 per share versus the Zacks Consensus Estimate of a loss of $0.03. This compares to loss of $0.44 per share a year ago.
Alimera Sciences Reports Second Quarter 2024 Results
07:30am, Tuesday, 06'th Aug 2024
ATLANTA, Aug. 06, 2024 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera”), a global pharmaceutical company whose mission is to be invaluable to patients, physicians and partners
ALIM ALERT: The M&A Class Action Firm Investigates Merger of The Alimera Sciences, Inc.
01:00pm, Saturday, 27'th Jul 2024
New York, July 27, 2024 (GLOBE NEWSWIRE) -- NEW YORK, July 27, 2024 / GlobeNewswire/-- Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered money for shareholders and is recogni
SHAREHOLDER ALERT: The M&A Class Action Firm Investigates Merger of The Alimera Sciences, Inc. - ALIM
03:52pm, Friday, 26'th Jul 2024
NEW YORK , July 26, 2024 /PRNewswire/ -- Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securit
SHAREHOLDER ALERT: The M&A Class Action Firm Investigates Merger of The Alimera Sciences, Inc. – ALIM
03:52pm, Wednesday, 03'rd Jul 2024
NEW YORK, July 03, 2024 (GLOBE NEWSWIRE) -- Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS
SHAREHOLDER ALERT: The M&A Class Action Firm Investigates Merger of The Alimera Sciences, Inc. - ALIM
06:35pm, Tuesday, 02'nd Jul 2024
NEW YORK , July 2, 2024 /PRNewswire/ -- Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securiti
SHAREHOLDER ALERT: Weiss Law Investigates Alimera Sciences, Inc.
09:40pm, Wednesday, 26'th Jun 2024
NEW YORK, NY / ACCESSWIRE / June 26, 2024 / Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Alimera Sciences, Inc. ("Alimera" or
Alimera (ALIM) Rises on Merger Deal With ANI Pharmaceuticals
12:05pm, Tuesday, 25'th Jun 2024
Alimera (ALIM) is set to be acquired by ANI Pharmaceuticals for approximately $381 million in upfront consideration. The transaction is expected to close in the third quarter of 2024.
Dow Jumps 300 Points; Alimera Sciences Shares Spike Higher
01:06pm, Monday, 24'th Jun 2024
U.S. stocks traded mixed midway through trading, with the Dow Jones index gaining more than 300 points on Monday.
Shareholder Alert: Ademi LLP investigates whether Alimera Sciences, Inc. has obtained a Fair Price for its Public Shareholders
12:39pm, Monday, 24'th Jun 2024
MILWAUKEE , June 24, 2024 /PRNewswire/ -- Ademi LLP is investigating Alimera (Nasdaq: ALIM) for possible breaches of fiduciary duty and other violations of law in its transaction with ANI Pharmaceut
Why Is Alimera Sciences (ALIM) Stock Up 77% Today?
11:31am, Monday, 24'th Jun 2024
Alimera Sciences (NASDAQ: ALIM ) stock is rocketing higher on Monday after the pharmaceutical company announced an acquisition deal with ANI Pharmaceuticals (NASDAQ: ANIP ). This agreement will have A
